MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA-Reference-Cited by-同舟云学术

MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA

Published:2021-10-25 Issue: Volume: Page:
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Wei Jinying¹²,Meng Guangping¹,Wu Jing²,Wang Ying³,Zhang Qiang²,Dong Ting²,Bao Jin⁴,Wang Chunyan²,Zhang Jie¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun 130021, P. R. China

2. Department of General Practice, The First Hospital of Jilin University, Changchun 130021, P. R. China

3. Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun 130021, P. R. China

4. Department of Health Examination Center, The First Hospital of Jilin University, Changchun 130021, P. R. China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1993718

Reference54 articles.

1. [1] Gonzalez-Marron A, Martin-Sanchez JC, Miro Q, et al. Relation between tobacco control policies and population at high risk of lung cancer in the European Union. Environ Res. 2019;179(Pt A):108594.

2. [2] Wei X, Shen X, Ren Y, et al. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer. Curr Pharm Des. 2018;23(39):5983-5988.

3. [3] Szejniuk WM, Robles AI, McCulloch T, et al. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J. 2019;19(1):5-14.

4. [4] Gong FY, Bai T, Zhang DY, et al. Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer. Curr Pharm Des. 2018;23(39):5973-5982.

5. [5] Petrek H, Yu AM. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential. Pharmacol Res Perspect. 2019;7(6):e00528.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of sirtuins in non‑small cell lung cancer (Review);Oncology Reports;2024-07-30

2. MicroRNA‑373‑3p inhibits the proliferation and invasion of non‑small‑cell lung cancer cells by targeting the GAB2/PI3K/AKT pathway;Oncology Letters;2024-03-22

3. SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy;Cancers;2023-12-26

4. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance;International Journal of Molecular Sciences;2023-11-19

5. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response;Pathology - Research and Practice;2023-11